A detailed history of Candriam S.C.A. transactions in Hologic Inc stock. As of the latest transaction made, Candriam S.C.A. holds 1,137,379 shares of HOLX stock, worth $88.2 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
1,137,379
Previous 1,343,586 15.35%
Holding current value
$88.2 Million
Previous $99.8 Million 7.13%
% of portfolio
0.54%
Previous 0.61%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$73.48 - $83.64 $15.2 Million - $17.2 Million
-206,207 Reduced 15.35%
1,137,379 $92.7 Million
Q2 2024

Aug 05, 2024

SELL
$71.43 - $78.41 $2.02 Million - $2.22 Million
-28,331 Reduced 2.07%
1,343,586 $99.8 Million
Q1 2024

May 03, 2024

BUY
$71.33 - $77.96 $2.7 Million - $2.95 Million
37,878 Added 2.84%
1,371,917 $107 Million
Q4 2023

Feb 14, 2024

BUY
$65.11 - $72.63 $2.69 Million - $3 Million
41,307 Added 3.2%
1,334,039 $95.3 Million
Q3 2023

Nov 13, 2023

BUY
$69.24 - $81.9 $1.73 Million - $2.05 Million
25,037 Added 1.98%
1,292,732 $89.7 Million
Q2 2023

Aug 08, 2023

BUY
$77.76 - $87.67 $781,799 - $881,434
10,054 Added 0.8%
1,267,695 $103 Million
Q1 2023

May 12, 2023

BUY
$75.55 - $86.16 $14.7 Million - $16.7 Million
194,125 Added 18.25%
1,257,641 $101 Million
Q4 2022

Feb 13, 2023

BUY
$61.6 - $76.99 $106,937 - $133,654
1,736 Added 0.16%
1,063,516 $79.6 Million
Q3 2022

Nov 10, 2022

BUY
$62.71 - $73.47 $10.4 Million - $12.1 Million
165,226 Added 18.43%
1,061,780 $68.5 Million
Q2 2022

Aug 03, 2022

BUY
$67.12 - $79.99 $2.05 Million - $2.44 Million
30,479 Added 3.52%
896,554 $62.1 Million
Q1 2022

May 13, 2022

SELL
$68.08 - $76.82 $18.6 Million - $21 Million
-273,099 Reduced 23.97%
866,075 $66.5 Million
Q4 2021

Feb 10, 2022

BUY
$68.97 - $77.92 $41.6 Million - $47.1 Million
603,846 Added 112.8%
1,139,174 $87.2 Million
Q3 2021

Nov 09, 2021

BUY
$67.56 - $80.74 $9.4 Million - $11.2 Million
139,145 Added 35.12%
535,328 $39.5 Million
Q2 2021

Jul 20, 2021

SELL
$60.52 - $76.68 $33.9 Million - $42.9 Million
-559,548 Reduced 58.55%
396,183 $26.4 Million
Q1 2021

Apr 29, 2021

SELL
$68.76 - $83.72 $1,856 - $2,260
-27 Reduced -0.0%
955,731 $66.9 Million
Q4 2020

Jan 22, 2021

BUY
$65.85 - $76.67 $8.23 Million - $9.59 Million
125,023 Added 15.05%
955,758 $69.6 Million
Q3 2020

Oct 19, 2020

BUY
$56.85 - $73.32 $8.97 Million - $11.6 Million
157,737 Added 23.44%
830,735 $55.2 Million
Q2 2020

Jul 23, 2020

BUY
$32.7 - $57.0 $10.4 Million - $18.1 Million
317,739 Added 89.44%
672,998 $38.4 Million
Q1 2020

May 26, 2020

BUY
$29.38 - $54.65 $2,908 - $5,410
99 Added 0.03%
355,259 $18.1 Million
Q4 2019

Jan 21, 2020

BUY
$45.61 - $53.56 $6.35 Million - $7.46 Million
139,296 Added 64.53%
355,160 $19,000
Q3 2019

Oct 21, 2019

BUY
$47.08 - $51.5 $2.79 Million - $3.05 Million
59,295 Added 37.87%
215,864 $11,000
Q2 2019

Aug 01, 2019

BUY
$43.0 - $49.21 $3.63 Million - $4.15 Million
84,328 Added 116.73%
156,569 $7.49 Million
Q1 2019

May 02, 2019

BUY
$38.28 - $48.4 $2.3 Million - $2.9 Million
59,981 Added 489.24%
72,241 $3.5 Million
Q4 2018

Feb 14, 2019

BUY
$37.76 - $44.89 $462,937 - $550,351
12,260 New
12,260 $504,000

Others Institutions Holding HOLX

About HOLOGIC INC


  • Ticker HOLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 249,652,992
  • Market Cap $19.4B
  • Description
  • Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The...
More about HOLX
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.